CGTX

Cognition Therapeutics Inc
1.91
0.00 (0.0%)
1.91
Volume 0
Bid Price 1.86
Ask Price 2.02
News -
Day High

Low
1.07

52 Week Range

High
6.2686

Day Low
Company Name Stock Ticker Symbol Market Type
Cognition Therapeutics Inc CGTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.91 04:00:00
Open Price Low Price High Price Close Price Prev Close
1.91
Trades Volume Avg Volume 52 Week Range
0 0 - 1.07 - 6.2686
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 1.91 USD

Period:

Draw Mode:

Cognition Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 55.37M 28.99M 21.85M $ - $ - -3.13 -0.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 3.21M 0.30%

more financials information »

Cognition Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CGTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.902.141.832.0398,9860.010.53%
1 Month2.102.3311.832.0365,696-0.19-9.05%
3 Months1.473.511.312.51191,7260.4429.93%
6 Months2.613.511.072.24143,751-0.70-26.82%
1 Year4.236.26861.072.95211,159-2.32-54.85%
3 Years12.1513.801.073.91186,434-10.24-84.28%
5 Years12.1513.801.073.91186,434-10.24-84.28%

Cognition Therapeutics Description

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.